Biphasic Human Insulin 30
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Biphasic Human Insulin 30, covering 2011-04-11 to 2017-02-20. Get the full timeline:
Most recent: Clinical Trial Update: Comparison of Efficacy and Safety of Repaglinide Combined With Insulin NPH Versus Biphasic Human Insulin 30 Alone in Inadequately Controlled Subjects With Type 2 Diabetes [Phase 4]